GEN-R

Welcome to the Brand page for “GEN-R”, which is offered here for Medical services, medical services utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, therapeutic regulation of immune cells; medical services for treatment of cancer;scientific and technological services and biological research and development relating thereto, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, therapeutic regulation of immune cells; scientific and technological services and biological research and development, research and development related to treatment of cancer;.

Its status is currently believed to be active. Its class is unavailable. “GEN-R” is believed to be currently owned by “Lyell Immunopharma, Inc.”

Owner:
LYELL IMMUNOPHARMA, INC.
Owner Details
Description:
Medical services, medical services utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, therapeutic regulation of immune cells; medical services for treatment of cancer;Scientific and technological services and biological research and development relating thereto, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, therapeutic regulation of immune cells; scientific and technological services and biological research and development, research and development related to treatment of cancer;
Categories: MEDICAL SERVICES